FDA Accepts Supplemental New Drug Application (sNDA) for DALVANCE® (dalbavancin)
October 09, 2015 at 07:01 AM EDT
Allergan plc (NYSE: AGN) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Allergan's supplemental New ...